Cognito Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.cognitotx.com
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
Not Applicable
- Conditions
- Alzheimer DiseaseMild Cognitive ImpairmentADDementia ModerateDementia AlzheimersDementia of Alzheimer TypeCognitive ImpairmentDementia, Mild
- Interventions
- Device: Sensory Stimulation System (GS120) - Active
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Cognito Therapeutics, Inc.
- Target Recruit Count
- 402
- Registration Number
- NCT06245031
- Locations
- 🇺🇸
Syrentis Clinical Research, Santa Ana, California, United States
🇺🇸Brain Matters Research, Delray Beach, Florida, United States
🇺🇸Neuropsychiatric Research Center of Southwest Florida, Fort Myers, Florida, United States
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011)
Not Applicable
- Conditions
- Alzheimer Disease 2Alzheimer Disease 17Alzheimer's Dementia Late OnsetAlzheimer Disease 1Alzheimer Disease 6Alzheimer Disease 10Alzheimer Disease 13Dementia of Alzheimer TypeDementia ModerateDementia Senile
- Interventions
- Device: Sensory Stimulation System (GS120) - ActiveDevice: Sensory Stimulation System (GS120) - Sham
- First Posted Date
- 2022-12-05
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Cognito Therapeutics, Inc.
- Target Recruit Count
- 670
- Registration Number
- NCT05637801
- Locations
- 🇺🇸
CCT Research - Gilbert Neurology Partners, Gilbert, Arizona, United States
🇺🇸Barrow Neurological Institute, Phoenix, Arizona, United States
🇺🇸CCT Research - Foothills Research Center, Phoenix, Arizona, United States
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
Not Applicable
- Conditions
- Alzheimer Disease, Early OnsetAlzheimer DiseaseMemory ImpairmentAlzheimer Disease, Late OnsetCognitive ImpairmentDementia, MildMild Cognitive ImpairmentDementia, Alzheimer TypeAlzheimer DementiaMemory Disorders
- Interventions
- Device: GammaSense Stimulation System (non-invasive, non-significant risk)
- First Posted Date
- 2018-09-07
- Last Posted Date
- 2021-08-24
- Lead Sponsor
- Cognito Therapeutics, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT03661034
- Locations
- 🇺🇸
Boston Center for Memory, Newton, Massachusetts, United States
Multi-Center Study of Sensory Stimulation to Improve Brain Function
Not Applicable
Active, not recruiting
- Conditions
- Alzheimer DiseaseMild Cognitive ImpairmentDementia AlzheimersDementiaCognitive ImpairmentDementia, MildCognitive Impairment, MildCognitive DeclineDementia, Alzheimer TypeDementia of Alzheimer Type
- Interventions
- Device: GammaSense Stimulation System (Active Settings)Device: GammaSense Stimulation System (Sham Settings)
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2021-08-24
- Lead Sponsor
- Cognito Therapeutics, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT03556280
- Locations
- 🇺🇸
ActivMed Practices & Research, Inc, Methuen, Massachusetts, United States
🇺🇸Brain Matters Research, Stuart, Florida, United States
🇺🇸Boston Center for Memory, Newton, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath